Wufu Liduo Pian (五氟利多片)五氟利多片
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 黑龙江福和华星制药集团股份有限公司Chinese legal name: 黑龙江福和华星制药集团股份有限公司
主要成分Active Ingredients
- 五氟利多Wufu Liduo
药物知识说明
五氟利多是一种在国家药监局注册认定的药品。该药品含有五氟利多-4671301c等成分。
该药品关联的活性成分包括:五氟利多Wufu Liduo。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为:黑龙江福和华星制药集团股份有限公司Chinese legal name: 黑龙江福和华星制药集团股份有限公司。
您可以探索含有相同成分的其他药品:五氟利多-4671301c成分药品。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 五氟利多片) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 五氟利多Wufu Liduo.
Manufacturers recorded for this product: 黑龙江福和华星制药集团股份有限公司Chinese legal name: 黑龙江福和华星制药集团股份有限公司.
Explore other medicines containing the same ingredient: 五氟利多 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 五氟利多片Recorded Chinese name: 五氟利多片
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 20mg。20 mg
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 黑龙江福和华星制药集团股份有限公司Chinese legal name: 黑龙江福和华星制药集团股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H23020234
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H23020234
Manufacturer
Chinese legal name: 黑龙江福和华星制药集团股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H23020234
生产企业
黑龙江福和华星制药集团股份有限公司(国产)
适应症
本品用于治疗各型精神分裂症,更适用于病情缓解者的维持治疗。
用法用量
口服 治疗剂量范围20~120mg,一周一次。宜从每周10~20mg开始,逐渐增量,每一周或两周增加10~20mg,以减少锥体外系反应。通常治疗量为一周30~60mg,待症状消失用原剂量继续巩固3个月,维持剂量一周10~20mg。
不良反应
主要为锥体外系反应,如静坐不能,急性肌张力障碍和类帕金森病。长期大量使用可发生迟发性运动障碍,亦可发生嗜睡,乏力,口干,月经失调,溢乳,焦虑或抑郁反应等。偶见过敏性皮疹,心电图异常,粒细胞减少及恶性综合征。
禁忌
基底神经节病变、帕金森病、帕金森综合征、骨髓抑制患者以及对本品过敏者禁用。
注意事项
肝、肾功能不全者慎用。不宜与其它抗精神病药合用、避免增加锥体外系反应的危险性。应定期检查肝功能与白细胞计数。用药期间不宜驾驶车辆、操作机械或高空作业。
贮藏
密封,置阴凉处。
规格
20mg。
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.